The J Craig Venter Institute, 9704 Medical Center Drive, Rockville, MD 20850, USA.
BMC Biol. 2010 May 25;8:70. doi: 10.1186/1741-7007-8-70.
A new family of natural products has been described in which cysteine, serine and threonine from ribosomally-produced peptides are converted to thiazoles, oxazoles and methyloxazoles, respectively. These metabolites and their biosynthetic gene clusters are now referred to as thiazole/oxazole-modified microcins (TOMM). As exemplified by microcin B17 and streptolysin S, TOMM precursors contain an N-terminal leader sequence and C-terminal core peptide. The leader sequence contains binding sites for the posttranslational modifying enzymes which subsequently act upon the core peptide. TOMM peptides are small and highly variable, frequently missed by gene-finders and occasionally situated far from the thiazole/oxazole forming genes. Thus, locating a substrate for a particular TOMM pathway can be a challenging endeavor.
Examination of candidate TOMM precursors has revealed a subclass with an uncharacteristically long leader sequence closely related to the enzyme nitrile hydratase. Members of this nitrile hydratase leader peptide (NHLP) family lack the metal-binding residues required for catalysis. Instead, NHLP sequences display the classic Gly-Gly cleavage motif and have C-terminal regions rich in heterocyclizable residues. The NHLP family exhibits a correlated species distribution and local clustering with an ABC transport system. This study also provides evidence that a separate family, annotated as Nif11 nitrogen-fixing proteins, can serve as natural product precursors (N11P), but not always of the TOMM variety. Indeed, a number of cyanobacterial genomes show extensive N11P paralogous expansion, such as Nostoc, Prochlorococcus and Cyanothece, which replace the TOMM cluster with lanthionine biosynthetic machinery.
This study has united numerous TOMM gene clusters with their cognate substrates. These results suggest that two large protein families, the nitrile hydratases and Nif11, have been retailored for secondary metabolism. Precursors for TOMMs and lanthionine-containing peptides derived from larger proteins to which other functions are attributed, may be widespread. The functions of these natural products have yet to be elucidated, but it is probable that some will display valuable industrial or medical activities.
现已描述了一类新的天然产物,其由核糖体产生的肽中的半胱氨酸、丝氨酸和苏氨酸分别转化为噻唑、噁唑和甲噁唑。这些代谢产物及其生物合成基因簇现在被称为噻唑/噁唑修饰的微菌素 (TOMM)。以微菌素 B17 和链球菌溶血素 S 为例,TOMM 前体包含 N 端前导序列和 C 端核心肽。前导序列包含翻译后修饰酶的结合位点,随后这些酶作用于核心肽。TOMM 肽很小且高度可变,基因预测器通常会错过它们,并且它们偶尔位于形成噻唑/噁唑的基因很远的地方。因此,定位特定 TOMM 途径的底物可能是一项具有挑战性的工作。
对候选 TOMM 前体的检查揭示了一个具有异常长的前导序列的亚类,该序列与腈水解酶密切相关。该家族成员缺乏催化所需的金属结合残基。相反,NHLP 序列显示经典的 Gly-Gly 切割基序,并且 C 端区域富含可杂环化的残基。NHLP 家族表现出相关的物种分布和与 ABC 转运系统的局部聚类。这项研究还提供了证据表明,另一个家族,注释为固氮蛋白 Nif11,可以作为天然产物前体 (N11P),但并不总是 TOMM 类型。事实上,许多蓝藻基因组显示出广泛的 N11P 旁系扩张,例如 Nostoc、Prochlorococcus 和 Cyanothece,它们用硫氨酸生物合成机制取代了 TOMM 簇。
本研究将许多 TOMM 基因簇与其相应的底物联系起来。这些结果表明,两个大型蛋白质家族,即腈水解酶和 Nif11,已经被重新用于次生代谢。源自更大蛋白质的 TOMM 和含硫氨酸的肽的前体,这些蛋白质具有其他功能,可能很普遍。这些天然产物的功能尚未阐明,但很可能其中一些将显示出有价值的工业或医学活性。